While less effective, in these tumor-macrophage co-cultures—which represent a stronger model of resistance than cancer cells alone—CURC-loaded SLNs also significantly re-sensitized resistant cells to doxorubicin by the reducing the transcription of Pgp mediated by the ROS/NF-kB axis. Here, NFKB1 is linked to cancer.